10-year lung cancer-specific survival of 80 percent reported in 2006 persisted, with 81 percent survival at 20 years
At three, six, and nine years, overall survival was 64, 43, and 26 percent and progression-free survival was 88, 78, and 78 percent, respectively
Furthermore, consistency of lung cancer may be an important predictor of survival
Patients with stage IV non-small cell lung cancer who are 65 years of age or older may be undertreated
Risk for recurrence increased with surgical delay beyond 12 weeks; overall survival improved with surgery within 12 weeks